The latest closing stock price for TransCode Therapeutics as of February 21, 2025 is 8.07.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $526 today, roughly 1 times their original investment - a 11.15% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 11.80 on February 10, 2025.
The TransCode Therapeutics 52-week high stock price is 16.73, which is 107.3% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.22, which is 97.3% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 1.90.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $526 today, roughly 1 times their original investment - a 11.15% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 11.80 on February 10, 2025.
The TransCode Therapeutics 52-week high stock price is 16.73, which is 107.3% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.22, which is 97.3% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 1.90.